Lilly’s retatrutide shows 28.3% weight loss in phase 3 trial

3 sources covered this ⚠ Left-only compare →

Coverage diverges in the emphasis placed on the drug's potential compared to existing treatments. CBS News highlights the drug's superior results over current options, framing it as a significant advancement in weight-loss therapies. In…